• +972-3-9683980
  • news@bard-isus.com


The Israel Innovation Authority (IIA) and the United-States Israel Binational Agricultural Research & Development Fund (BARD) are excited to launch the new Academic to Business Leverage, the B-Lever Program.


If you are considering commercializing and need a partner in planning how to go-to-market and fund your project, this is your opportunity to take your research to the next level


About the program
B-Lever is a new funding-  opportunity for Israeli scientists to collaborate with American scientists and small business.  It encourages technological knowledge transfer between academia or research institutes and commercial companies.


Program Goal
Its goal is to foster private-sector commercialization of innovative agricultural technologies, products and services developed through collaborative research of Israeli and U.S. scientists.



Under B-Lever, an Israeli company can apply for a Magneton grant from the Israel Innovation Authority (IIA) for up to $1,000,000 for two years.  Additional funding mechanisms may apply.
U.S. team members who are part of a BARD project can participate with a small business applying for funding under the USDA’s SBIR program.


Guidelines for B-Lever program

At the end of the second year of a BARD-supported project, U.S. and Israeli joint research teams under BARD may link to a commercial entity from either country.  BARD-supported scientists can collaborate with the U.S. and/or Israeli business, so the results of the combined research will enhance the development of a marketable technology, product or service.
U.S. team members in the BARD-supported project can participate with a small business applying for funding under the USDA
SBIR program. SBIR applicants must be small businesses with majority U.S. ownership or control.  SBIR Phase I grants are limited to $100,000 and duration of 8 months and are open to any small business concern that meets the SBIR eligibility requirements. SBIR Phase II grants are limited to $600,000 and duration of 24 months and are only open to previous Phase I awardees.

Further Information


Contact Us